Posted on 3月 17, 20233/17/23
Successfully Navigating Self-Commercialisation in Europe
Posted on 3月 15, 20233/15/23
Successful Launches in Europe: Complex, but Not Complicated?
Posted on 3月 1, 20233/1/23
The Future of Pharma – A Provocative Perspective
Posted on 11月 13, 202211/13/22
Establishing the Patient Access Mission During Clinical Development
Posted on 9月 19, 20229/19/22
How Specialty Pharmacies Can Elevate Your Channel and Distribution Strategy for HCP-administered Buy & Bill Products
Posted on 8月 4, 20228/4/22
Macroeconomic Factors Impact Cash Flow for Pharma
Posted on 6月 1, 20226/1/22
New Medicines, New Access, New Frontiers
Posted on 4月 14, 20224/14/22
Impact of Patient Reported Outcome Measures on HTA Decisions for Rare Diseases
Posted on 4月 1, 20224/1/22
What You Need to Know as the European Union Embarks on Joint Health Technology Assessment (HTA)
Posted on 3月 23, 20223/23/22